For the twelve months ended Jun 30, 2026, Dyadic International Inc. reported $3.80M of revenue and -$7.62M of net income.
DYAI revenue was $961.1K in fiscal Q2 2026 (ended Jun 30, 2026), down 0.6% from a year earlier and down 13.5% from the prior quarter. For the full fiscal 2025 it was $3.09M, down 11.6% from fiscal 2024. Compound annual growth was +14.0% over 5 years. It rose in 5 of the last 8 fiscal years.
DYAI net income was -$2.12M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$1.79M a year earlier. For the full fiscal 2025 it was -$7.36M, compared with -$5.81M in fiscal 2024.
DYAI diluted EPS was -$0.06 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.06 a year earlier. For the full fiscal 2025 it was -$0.23, compared with -$0.20 in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.09M | $3.50M | $2.90M | $2.93M | $2.40M | $1.60M | $1.68M | $1.30M | $758.4K |
| Cost of revenue | $2.32M | $1.19M | $1.98M | $2.12M | $1.94M | $1.42M | $1.46M | $1.03M | $680.2K |
| Gross profit | $770.5K | $2.30M | $923.0K | $807.1K | $459.4K | $177.0K | $221.4K | $268.2K | $78.2K |
| Research and development | $2.15M | $2.04M | $3.30M | $4.50M | $8.39M | $3.87M | $3.09M | $2.10M | $1.77M |
| Selling, general and admin | $5.76M | $6.13M | $5.82M | $6.42M | $6.70M | $6.08M | $5.52M | $4.52M | $5.03M |
| Operating income | -$7.19M | -$5.90M | -$8.23M | -$10.17M | -$14.73M | -$10.03M | -$9.28M | -$7.59M | -$7.13M |
| Income tax | - | - | - | - | $0 | $31.3K | $10.3K | -$1.01M | -$66.7K |
| Net income | -$7.36M | -$5.81M | -$6.80M | -$9.74M | -$13.07M | -$9.33M | -$8.31M | -$5.69M | -$2.14M |
| EPS, basic | -$0.23 | -$0.20 | -$0.24 | -$0.34 | -$0.47 | -$0.34 | -$0.31 | -$0.21 | -$0.07 |
| EPS, diluted | -$0.23 | -$0.20 | - | - | -$0.47 | -$0.34 | -$0.31 | -$0.21 | -$0.07 |
| Diluted shares | 32.6M | 29.3M | - | - | 27.8M | 27.5M | 27.0M | 27.7M | 28.9M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.62M | $6.51M | $6.52M | $5.79M | $15.75M | $20.64M | $4.82M | $2.39M | $5.79M |
| Short-term investments | $2.70M | $2.76M | - | - | - | - | - | - | - |
| Receivables | $1.09M | $237.0K | $466.2K | $330.0K | $277.8K | $294.2K | $558.5K | $318.7K | $271.0K |
| Current assets | $9.90M | $9.83M | $8.07M | $13.42M | $21.01M | $29.78M | $35.64M | $42.75M | $49.62M |
| Total assets | $9.95M | $9.93M | $8.22M | $13.71M | $21.30M | $30.07M | $37.45M | $43.30M | $50.74M |
| Current liabilities | $3.69M | $2.45M | $2.25M | $2.45M | $2.56M | $1.63M | $1.59M | $849.6K | $768.9K |
| Total liabilities | $8.71M | $7.46M | $2.34M | $2.63M | $2.91M | $1.63M | - | - | - |
| Shareholders' equity | $1.23M | $2.47M | $5.88M | $11.09M | $18.39M | $28.45M | $35.86M | $42.45M | $49.98M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.70M | -$3.97M | -$6.73M | -$8.08M | -$11.28M | -$6.57M | -$5.78M | -$4.41M | -$1.69M |
| Investing cash flow | $82.1K | -$1.88M | $7.45M | -$2.37M | $5.22M | $22.12M | $7.71M | $3.33M | -$812.1K |
| Financing cash flow | $4.96M | $5.85M | $0 | $543.6K | $1.23M | $255.5K | $550.2K | -$2.30M | -$6.22M |
| Share repurchases | - | - | - | - | - | - | $0 | $2.30M | $6.22M |
| Stock-based compensation | $930.2K | $1.13M | $1.24M | $1.89M | $1.78M | $1.65M | $1.17M | $467.2K | $643.4K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -11.6% | 20.6% | -1.1% | 21.9% | 50.1% | -4.7% | 29.8% | 70.8% | - |
| Gross margin | 24.9% | 65.8% | 31.8% | 27.5% | 19.1% | 11.0% | 13.2% | 20.7% | 10.3% |
| Operating margin | -232.8% | -168.8% | -283.9% | -346.9% | -612.7% | -625.9% | -552.2% | -586.1% | -939.7% |
| Net margin | -238.3% | -166.2% | -234.4% | -332.2% | -543.7% | -582.1% | -494.2% | -439.4% | -281.6% |
| Return on equity | -597.6% | -235.2% | -115.6% | -87.8% | -71.1% | -32.8% | -23.2% | -13.4% | -4.3% |
| Return on assets | -74.0% | -58.5% | -82.7% | -71.0% | -61.4% | -31.0% | -22.2% | -13.1% | -4.2% |
| Current ratio | 2.68 | 4.01 | 3.58 | 5.48 | 8.22 | 18.32 | 22.44 | 50.31 | 64.53 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $961.1K | $1.11M | $565.5K | $1.16M | $966.6K | $393.6K | $817.4K | $1.96M | $385.9K | $334.6K | $686.5K | $397.1K |
| Cost of revenue | $984.2K | $791.8K | $384.6K | $1.02M | $613.6K | $297.7K | $352.8K | $395.9K | $302.0K | $144.0K | $350.1K | $105.9K |
| Gross profit | -$23.0K | $319.1K | $180.9K | $140.6K | $353.0K | $95.9K | $464.6K | $1.56M | $83.9K | $190.7K | $336.4K | $291.2K |
| Research and development | $332.6K | $476.1K | $458.4K | $571.9K | $629.4K | $495.0K | $545.7K | $460.2K | $515.6K | $522.7K | $852.8K | $716.4K |
| Selling, general and admin | $1.69M | $1.76M | $1.25M | $1.48M | $1.44M | $1.60M | $1.44M | $1.30M | $1.61M | $1.79M | $1.65M | $1.28M |
| Operating income | -$2.05M | -$1.90M | -$1.54M | -$1.93M | -$1.73M | -$2.00M | -$1.53M | -$202.6K | -$2.04M | -$2.13M | -$2.17M | -$1.72M |
| Income tax | $0 | $0 | - | - | - | - | - | - | - | - | - | - |
| Net income | -$2.12M | -$1.95M | -$1.57M | -$1.98M | -$1.79M | -$2.03M | -$1.55M | -$203.5K | -$2.05M | -$2.01M | -$2.07M | -$1.61M |
| EPS, basic | -$0.06 | -$0.05 | -$0.04 | -$0.06 | -$0.06 | -$0.07 | - | -$0.01 | -$0.07 | -$0.07 | - | -$0.06 |
| EPS, diluted | -$0.06 | -$0.05 | -$0.04 | -$0.06 | -$0.06 | -$0.07 | - | -$0.01 | -$0.07 | - | - | - |
| Diluted shares | 36.4M | 36.4M | - | 34.5M | 30.1M | 29.9M | - | 29.5M | 29.3M | - | - | - |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.43M | $4.25M | $4.62M | $5.83M | $2.14M | $5.06M | $6.51M | $5.92M | $6.13M | $10.57M | $6.52M | $7.40M |
| Short-term investments | $1.69M | $1.36M | $2.70M | $3.10M | $2.84M | $2.31M | $2.76M | - | - | - | - | - |
| Receivables | $1.30M | $996.5K | $1.09M | $916.6K | $715.3K | $221.7K | $237.0K | $352.9K | $249.8K | $246.1K | $466.2K | $417.9K |
| Current assets | $6.41M | $7.70M | $9.90M | $11.55M | $7.41M | $7.81M | $9.83M | $10.69M | $10.50M | $12.54M | $8.07M | $9.09M |
| Total assets | $6.54M | $7.81M | $9.95M | $11.67M | $8.14M | $7.89M | $9.93M | $10.81M | $10.63M | $12.68M | $8.22M | $9.26M |
| Current liabilities | $3.88M | $3.18M | $3.69M | $4.05M | $3.66M | $1.96M | $2.45M | $2.08M | $1.95M | $2.26M | $2.25M | $1.46M |
| Total liabilities | $8.92M | $8.22M | $8.71M | $9.07M | $8.67M | $6.97M | $7.46M | $7.39M | $7.46M | $8.17M | $2.34M | $1.60M |
| Shareholders' equity | -$2.39M | -$407.7K | $1.23M | $2.61M | -$529.7K | $923.6K | $2.47M | $3.41M | $3.17M | $4.52M | $5.88M | $7.65M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.82M | -$1.96M | -$1.77M | -$1.85M | -$130.0K | -$1.95M | -$696.4K | -$201.1K | -$1.96M | -$1.11M | -$923.4K | -$1.96M |
| Investing cash flow | -$356.9K | $1.27M | $468.2K | $93.4K | -$961.6K | $482.1K | $1.26M | -$12.0K | -$2.47M | -$654.9K | $34.2K | $3.53M |
| Financing cash flow | - | - | -$1 | $4.94M | $0 | $24.2K | $24.3K | $0 | $0 | $5.82M | $0 | $0 |
| Stock-based compensation | $144.4K | $139.3K | $192.3K | $172.4K | $340.5K | $225.0K | $274.8K | $247.4K | $297.6K | $306.5K | $297.9K | $281.3K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -0.6% | 182.3% | -30.8% | -40.5% | 150.5% | 17.6% | 19.1% | 393.0% | -53.9% | -65.8% | -7.7% | -54.9% |
| Gross margin | -2.4% | 28.7% | 32.0% | 12.1% | 36.5% | 24.4% | 56.8% | 79.8% | 21.8% | 57.0% | 49.0% | 73.3% |
| Operating margin | -213.7% | -171.3% | -271.6% | -165.3% | -178.9% | -508.8% | -187.2% | -10.4% | -529.3% | -635.2% | -315.9% | -433.2% |
| Net margin | -221.0% | -175.9% | -277.1% | -169.7% | -185.6% | -515.2% | -189.7% | -10.4% | -530.0% | -600.6% | -301.8% | -406.6% |
| Current ratio | 1.65 | 2.42 | 2.68 | 2.85 | 2.02 | 3.98 | 4.01 | 5.15 | 5.39 | 5.54 | 3.58 | 6.24 |
Source: XBRL data Dyadic International Inc. files with the SEC, latest filing dated Aug 12, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| DYAI | $3.80M | -8.0% | -$7.62M | -200.5% | $15.2M |
| AMGN | $38.90B | +8.2% | $9.39B | 24.1% | $251.65B |
| GILD | $30.99B | +6.5% | -$3.86B | -12.5% | $210.01B |
| MRNA | $2.52B | +13.1% | -$2.79B | -110.5% | $107.39B |
| ARGX | $4.25B | +88.6% | $1.29B | 30.4% | $59.72B |
| RVMD | $0 | - | -$1.13B | - | $43.29B |
| BIIB | $10.30B | +2.3% | $347.50M | 3.4% | $37.67B |
| BNTX | €2.87B | +4.3% | -€1.14B | -39.6% | $21.98B |
| EXEL | $2.50B | +9.1% | $885.14M | 35.5% | $17.51B |